Forest Laboratories (NYSE:FRX) will report earnings before markets open on Tuesday, July 23rd. Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe.
Here is your Cheat Sheet to Forest Laboratories Earnings:
Earnings Expectations: Analysts expect earnings of $0.08 per share on revenues of $797.67 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.19 to a profit $0.14. For the current year, the average estimate is a profit of $0.88, which is worse than the estimate ninety days ago.
Here’s how Forest Laboratories has been performing on an annual basis:
|Revenue ($) in millions||3,923||4,193||4,420||4,586||3,126|
|Diluted EPS ($)||2.52||2.25||3.59||3.57||-0.12|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||821.13||760.64||722.69||821.67|
|Diluted EPS ($)||0.21||0.08||-0.58||0.17|
Forest Laboratories has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)